Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (161-170 of 309) with videos related to

Pageof 31
Sort By:
Plos One|April 15, 2014
Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapyChristopher J Miller, Jason V Baker, Alison M Bormann, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Determinants of HIV-1 Late Presentation in Patients Followed in EuropeMafalda N S Miranda, Marta Pingarilho, Victor Pimentel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppressionEugenia Negredo, Luís Cruz, Roger Paredes, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Current HIV Research|November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, SpainBeatriz Mothe, Iñaki Perez, Pere Domingo, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyMaria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
Medicine|March 23, 2017
Oral microbiome in HIV-associated periodontitisMarc Noguera-Julian, Yolanda Guillén, Jessica Peterson, et al.
Journal of Virology|November 30, 2018
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV ControllersMiriam Rosás-Umbert, Anuska Llano, Rocío Bellido, et al.
Scientific Reports|September 10, 2021
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective studyEdy Nacarapa, M Elisa Verdu, Joana Nacarapa, et al.
The Journal of Infectious Diseases|August 17, 2011
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapyRoger Paredes, Maria Carmen Puertas, Wendy Bannister, et al.
Pageof 31

Showing results (161-170 of 309) with videos related to

Sort By:
Pageof 31
Plos One|April 15, 2014
Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapyChristopher J Miller, Jason V Baker, Alison M Bormann, et al.
Pathogens (Basel, Switzerland)|August 6, 2021
Determinants of HIV-1 Late Presentation in Patients Followed in EuropeMafalda N S Miranda, Marta Pingarilho, Victor Pimentel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppressionEugenia Negredo, Luís Cruz, Roger Paredes, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Current HIV Research|November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, SpainBeatriz Mothe, Iñaki Perez, Pere Domingo, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyMaria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
Medicine|March 23, 2017
Oral microbiome in HIV-associated periodontitisMarc Noguera-Julian, Yolanda Guillén, Jessica Peterson, et al.
Journal of Virology|November 30, 2018
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV ControllersMiriam Rosás-Umbert, Anuska Llano, Rocío Bellido, et al.
Scientific Reports|September 10, 2021
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective studyEdy Nacarapa, M Elisa Verdu, Joana Nacarapa, et al.
The Journal of Infectious Diseases|August 17, 2011
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapyRoger Paredes, Maria Carmen Puertas, Wendy Bannister, et al.
Pageof 31